Combination of caregiving stress and hormone replacement therapy is associated with prolonged platelet activation to acute stress among postmenopausal women

Psychosomatic Medicine

Volumn 69, Issue 9, 2007, Pages 910-917

  Aschbacher, Kirstin ^a   Von Känel, Roland ^a,b   Mills, Paul J ^a   Hong, Suzi ^a   Roepke, Susan K ^a   Mausbach, Brent T ^a   Patterson, Thomas L ^a,c   Ziegler, Michael G ^d   Dimsdale, Joel E ^a   Ancoli Israel, Sonia ^a,c   Grant, Igor ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Alzheimer's disease; Dementia; Fibrinogen receptor; GP IIb IIIa; P selectin; Platelet aggregates

Indexed keywords

ACETYLSALICYLIC ACID; ESTROGEN; FIBRINOGEN RECEPTOR; GESTAGEN; PADGEM PROTEIN; PROGESTERONE; TESTOSTERONE;

ACUTE STRESS; ADULT; AGED; ALZHEIMER DISEASE; ANTIGEN EXPRESSION; BLOOD FLOW; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAREGIVER; CHRONIC STRESS; CONFERENCE PAPER; CONTROLLED STUDY; DEMENTIA; FEMALE; FLOW CYTOMETRY; HEALTH BEHAVIOR; HORMONE SUBSTITUTION; HUMAN; JOB STRESS; LABORATORY TEST; MENTAL STRESS; MULTIVARIATE ANALYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGRESSION ANALYSIS; SPEECH; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE;

EID: 36349013175     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/PSY.0b013e31815a8ba8     Document Type: Conference Paper

References (67)

1. Kiecolt-Glaser JK, Dura JR, Speicher CE, Trask OJ, Glaser R. Spousal caregivers of dementia victims: longitudinal changes in immunity and health. Psychosom Med 1991;53:345-62.
2. von Känel R, Dimsdale JE, Adler KA, Patterson TL, Mills PJ, Grant I. Exaggerated plasma fibrin turnover (D-dimer) in Alzheimer caregivers as compared to noncaregiving controls. Gerontology 2005;51:7-13.
3. Aschbacher K, von Känel R, Dimsdale JE, Patterson TL, Mills PJ, Mausbach BT, Ancoli-Israel S, Grant I. Increasing dementia of the care receiver predicts procoagulant response in Alzheimer caregivers. Am J Geriatr Psychiatry 2006;14:694-703.
4. King AC, Oka RK, Young DR. Ambulatory blood pressure and heart rate responses to the stress of work and caregiving in older women. J Gerontol 1994;49:239-45.
5. Shaw WS, Patterson TL, Ziegler MG, Dimsdale JE, Semple SJ, Grant I. Accelerated risk of hypertensive blood pressure recordings among Alzheimer caregivers. J Psychosom Res 1999;46:215-27.
6. Patterson TL, Grant I. Interventions for caregiving in dementia: physical outcomes. Curr Opin Psychiatry 2003;16:629-33.
7. Schulz R, Beach SR. Caregiving as a risk factor for mortality: the caregiver health effects study. JAMA 1999;282:2215-9.
8. Schwartz AR, Gerin W, Davidson KW, Pickering TG, Brosschot JF, Thayer JF, Christenfeld N, Linden W. Toward a causal model of cardiovascular responses to stress and the development of cardiovascular disease. Psychosom Med 2003;65:22-35.
9. Shattil S, Budzynski A, Scrutton MC. Epinephrine induces platelet fibrinogen receptor expression, fibrinogen binding, and aggregation in whole blood in the absence of other excitatory agonists. Blood 1989;73:150-8.
10. Grant I, McKibbin CL, Taylor MJ, Mills P, Dimsdale J, Ziegler M, Patterson TL. In-home respite intervention reduces plasma epinephrine in stressed Alzheimer caregivers. Am J Geriatr Psychiatry 2003;11:62-72.
11. Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987;70:307-15.
12. Markovitz JH, Matthews KA. Platelets and coronary heart disease: potential psychophysiologic mechanisms. Psychosom Med 1991;53:643-68.
13. Merten M, Thiagarajan P. P-selectin expression on platelets determines size and stability of platelet aggregates. Circulation 2000;102:1931-6.
14. Michelson AD. Evaluation of platelet function by flow cytometry. Pathophysiol Haemost Thromb 2006;35:67-82.
15. Linden MD, Frelinger AL, Barnard MR, Przyklenk K, Furman MI, Michelson AD. Application of flow cytometry to platelet disorders. Semin Thromb Hemost 2004;30:501-11.
16. von Känel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Hematol J 2000;65:357-69.
17. Blann AD, Nadar SK, Lip GY. The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 2003;24:2166-79.
18. Tomer A. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry. J Biol Regul Homeost Agents 2004;18:172-7.
19. Musselman DL, Tomer A, Manatunga AK, Knight BT, Porter MR, Kasey S, Marzec U, Harker LA, Nemeroff CB. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996;153:1313-7.
20. Prescott SM, McIntyre TM, Zimmerman GA, Stafforini DM. Inflammation as an early component of atherosclerosis and vascular damage - a role for p-selectin and platelet activating factor. Jpn Circ J 1996;60:137-41.
21. Birk AV, Leno E, Robertson HD, Bolotina VM, Szeto HH. Interaction between ATP and catecholamines in stimulation of platelet aggregation. Am J Physiol Heart Circ Physiol 2003;284:619-25.
22. Writing Group for the Women's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-33.
23. Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, Stafford RS, Sidney S, Rosendaal FR. Estrogen plus progestin and risk of venous thrombosis. JAMA 2004;292:1573-80.
24. Smith NL, Heckbert SR, Lemaitre RN, Lumley T, Weiss NS, Larson EB, Rosendaal FR, Psaty BM. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA 2004;292:1581-7.
25. Vargas-Lorenzo C, Garcia-Rodriguez LA, Cattaruzzi C, Troncon MG, Agostinis L, Perez-Gutthann S. Hormone replacement therapy and risk of hospitalization for venous thromboembolism: a population-based study in Southern-Europe. Am J Epidemiol 1998;147:387-90.
26. Grady D, Wenger NK, Herrington D, Khan S, Furberg CD, Hunninghake D, Vittinghoff E, Hulley S. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. Ann Intern Med 2000;132:689-96.
27. Thijs A, van Baal WM, van der Mooren MJ, Kenemans P, Drager AM, Huijgens PC, Stehouwer CD. Effects of hormone replacement therapy on blood platelets. Eur J Clin Invest 2002;32:613-8.
28. Aune B, Oian P, Omsjo I, Osterud B. Hormone replacement therapy reduces the reactivity of monocytes and platelets in whole blood - a beneficial effect on atherogenesis and thrombus formation? Am J Obstet Gynecol 1995;173:1816-20.
29. Bar J, Tepper R, Fuchs J, Pardo Y, Goldberger S, Ovadia J. The effect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women. Obstet Gynecol 1993;81:261-4.
30. Koh KK, Yoon BK. Controversies regarding hormone therapy: insights from inflammation and hemostsis. Cardiovasc Res 2006;70:22-30.
31. Koh KK, Kang MH, Jin DK, Lee SK, Ahn JY, Hwang HY. Vascular effects of estrogen in type II diabetic postmenopausal women. J Am Coll Cardiol 2001;38:1409-15.
32. Koh KK, Blum A, Hathaway L, Mincemoyer R, Csako G, Waclawiw MA. Vascular effects of estrogen and vitamin E therapies in postmenopausal women. 1999;100:1851-7.
33. Kop WJ. The integration of cardiovascular behavioral medicine and psychoneuroimmunology: new developments based on converging research fields. Brain Behav Immun 2003;17:233-7.
34. Saab PG, Llabre MM, Hurwitz BE, Frame CA, Reineke LJ, Fins AI, McCalla J, Cieply LK, Schneiderman N. Myocardial and peripheral vascular responses to behavioral challenges and their stability in black and white Americans. Psychophysiology 1992;29:384-97.
35. Adler KA, Mills PJ, Dimsdale JE, Ziegler MG, Patterson TL, Sloan RP, Grant I. Temporal stability of acute stress-induced changes in leukocyte subsets and cellular adhesion molecules in older adults. Brain Behav Immun 2002;16:262-74.
36. von Känel R, Mills PJ, Fainman C, Dimsdale JE. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom Med 2001;63:531-44.
37. Aschbacher K, Patterson TL, von Känel R, Dimsdale JE, Mills PJ, Adler KA, Ancoli-Israel S, Grant I. Coping processes and hemostatic reactivity to acute stress in dementia caregivers. Psychsom Med 2005;67:964-71.
38. Chen MC, Wu CJ, HWC, Yip HK, Chen YH, Cheng CI, Chai HT. Mechanism of reducing platelet activity by percutaneous transluminal mitral valvuloplasty in patients with rheumatic mitral stenosis. 2004;125:1629-34.
39. Harrison P. Progress in the assessment of platelet function. Br J Haematol 2000;111:733-44.
40. Michelson A, Furman M. Laboratory markers of platelet activation and their clinical significance. Curr Opin Hematol 1999;6:342-8.
41. Derogatis LR. BSI: Administration scoring and procedures manual. Minneapolis, MN: National Computer Systems; 1993.
42. Piersma HL, Boes JL, Reaume WM. Unidimensionality of the brief symptom inventory (BSI) in adult and adolescent inpatients. J Pers Assess 1994;63:338-44.
43. Boulet J, Boss MW. Reliability and validity of the brief symptom inventory. Psychol Assess 1991;3:433-7.
44. Tabachnick BG, Fidell LS. Using multivariate statistics. Needham Heights, MA: Allyn and Bacon; 2001.
45. McKenzie ME, Malinin AI, Bell CR, Dzhanashvili A, Horowitz ED, Oshrine BR, Atar D, Serebruany VL. Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets. Blood Coagul Fibrinolysis 2003;14:249-53.
46. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 1994;330:1287-94.
47. Ault KA, Cannon CP, Mitchell J, McCahan J, Tracy RP, Novotny WF, Reimann JD, Braunwald E. Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. J Am Coll Cardiol 1999;33:634-9.
48. Strike PC, Magid K, Brydon L, Edwards S, McEwan JR, Steptoe A. Exaggerated platelet and hemodynamic reactivity to mental stress in men with coronary artery disease. Psychsom Med 2004;66:492-500.
49. Schulz R, O'Brien AT, Bookwala J, Fleissner K. Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes. Gerontologist 1995;35:771-91.
50. Vitaliano PP, Zhang J, Scanlan JM. Is caregiving hazardous to one's physical health? A meta-analysis. Psychol Bull 2003;129:946-72.
51. Strike PC, Perkins-Porras L, Whitehead DL, McEwan JR, Steptoe A. Triggering of acute coronary syndromes by physical exertion and anger: clinical and sociodemographic characteristics. Heart 2006;92:1035-40.
52. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998;98:2334-51.
53. Kop WJ. Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease. Psychosom Med 1999;61:476-87.
54. Johnson RC, Chapman SM, Dong ZM, Ordovas JM, Mayadas TN, Herz J, Hynes RO, Schaefer EJ, Wagner DD. Absence of P-selectin delays fatty streak formation in mice. J Clin Invest 1997;99:1037-43.
55. Merten M, Chow T, Hellums D, Thiagarajan P. A new role for P-selectin in shear-induced platelet aggregation. Circulation 2000;102:2045-50.
56. Hjemdahl P, Chronos NA, Wilson DJ, Bouloux P, Goodall AH. Epinephrine sensitizes human platelets in vivo and in vitro as studied by fibrinogen binding and P-selectin expression. Arterioscler Thromb Vasc Biol 1994;14:77-84.
57. Jin J, Kunapuli SP. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. PNAS 1998;95:8070-4.
58. de Clerk F, Xhonneux B, de Chaffoy de Courcelles D. Functional expression of the amplification reaction between serotonin and epinephrine on platelets. J Cardiovasc Pharmacol 1988;11:S1-S5.
59. Mausbach BT, Dimsdale JE, Ziegler MG, Mills PJ, Ancoli-Israel S, Patterson TL, Grant I. Depressive symptoms predict norepinephrine response to a psychological stressor task in Alzheimer's caregivers. Psychosom Med 2005;67:638-42.
60. Fink G, Summer BEH, Rosie R, Grace O, Quinn JP. Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol 1996;16:325-44.
61. Li N, Wallen NH, Ladjevardi M, Hjemdahl P. Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibinolysis 1997;8:517-23.
62. Miller VM, Shuster LT, Hayes SN. Controversy of hormone treatment and cardiovascular function: need for strengthened collaborations between preclinical and clinical scientists. Curr Opin Investig Drugs 2003;4:1220-32.
63. Nealson ML, Vjiayan KV, Bolton E, Bray PF. Human platelets contain a glycosylated estrogen receptor beta. Circ Res 2001;88:438-42.
64. Khetawat G, Faraday N, Nealen ML, Vijayan V, Bolton E, Noga SJ, Bray PF. Human megakaryocytes and platelets contain the estrogen receptor beta and androgen receptor (AR): testosterone regulates AR expression. Blood 2000;95:2289-96.
65. Burleson MH, Malarkey WB, Cacioppo JT, Poehlmann KM, Kiecolt-Glaser J, Berntson GG, Glaser R. Postmenopausal hormone replacement: effects on autonomic, neuroendocrine, and immune reactivity to brief psychological stressors. Psychosom Med 1998;60:17-25.
66. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, Azen SP. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998;128:262-9.
67. Monroe SM, Simons AD. Diathesis-stress theories in the context of life stress research: implications for the depressive disorders. Psychol Bull 1991;110:406-25.